Add-On ZIDA Sock Therapy for Overactive Bladder

Part of paid clinical trials in Charleston, South Carolina.

Sponsor
Medical University of South Carolina
Study ID
NCT07432659
Status
Recruiting
Apply to this trial

Conditions

  • Overactive Bladder

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • ZIDA Control Sock — DEVICE
    The ZIDA Control Sock is an FDA-cleared, noninvasive wearable neuromodulation device designed for home use. The device delivers low-level electrical stimulation near the ankle to stimulate peripheral nerves involved in bladder control. In this study, the device is used as an adjunct to usual pharmacologic care.

Study Details

Many people with overactive bladder (OAB) continue to experience symptoms despite pharmacologic treatment. This study evaluates the use of the ZIDA Control Sock, an FDA-cleared, noninvasive wearable device that delivers mild electrical stimulation near the ankle, as an adjunct to usual care. Adults with OAB-wet who remain symptomatic on stable medication will use the device at home once weekly for 12 weeks while continuing their prescribed therapy. The study collects clinical, patient-reported, and safety information during adjunctive device use.

Key Dates

Start date
Apr 17, 2026
Status verified
May 2026
Primary completion
Mar 31, 2028
Completion
Mar 31, 2028

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: ZIDA Add-On Therapy
    Participants will continue usual pharmacologic treatment for overactive bladder and will use the ZIDA Control Sock at home once weekly over the study treatment period. Device use is evaluated as an adjunct to standard care.

Primary Outcome Measure

Mean change in daily urgency urinary incontinence (UUI) episodes (3-day bladder diary) [ Time Frame: From baseline to at the end of treatment at 12 weeks ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Rutledge Tower at Medical University of South CarolinaCharlestonSouth Carolina29425
Louisa Keil
[email protected]
843-792-2300
Connie Wang, MD (PRINCIPAL_INVESTIGATOR)
Eric Rovner, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Charleston, SC

By research site
Rutledge Tower at Medical University of South Carolina· Charleston, SC

Related Studies